CD28 T cell costimulatory receptor function is negatively regulated by N-linked carbohydrates

Biochemical and Biophysical Research Communications

Volumn 317, Issue 1, 2004, Pages 60-67

  Ma, Bruce Y ^a   Mikolajczak, Sebastian A ^b,c   Yoshida, Tetsuya ^d   Yoshida, Ryoko ^d   Kelvin, David J ^b   Ochi, Atsuo ^b  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d FUKUOKA UNIVERSITY   (Japan)

Author keywords

Cell surface molecules; Costimulation; T lymphocytes

Indexed keywords

B7 ANTIGEN; CARBOHYDRATE DERIVATIVE; CD28 ANTIGEN; CD28I ANTIGEN; GLYCAN DERIVATIVE; GLYCOSIDASE INHIBITOR; INTERLEUKIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL ADHESION; CONTROLLED STUDY; GENE ACTIVITY; GLYCOSYLATION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT; T LYMPHOCYTE;

1-DEOXYNOJIRIMYCIN; ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD28; ANTIGENS, CD80; BINDING SITES; CARBOHYDRATE SEQUENCE; CELL ADHESION; CHO CELLS; CRICETINAE; GLYCOSIDE HYDROLASES; GLYCOSYLATION; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; SWAINSONINE; T-LYMPHOCYTES; TRANSFECTION;

EID: 1642545217     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.012     Document Type: Article

References (20)

1. Rudd P.M., Elliott T., Cresswell P., Wilson I.A., Dwek R.A. Glycosylation and the immune system. Science. 291:2001;2370-2376.
2. Helenius A., Aebi M. Intracellular functions of N-linked glycans. Science. 291:2001;2364-2369.
3. Demetriou M., Granovsky M., Quaggin S., Dennis J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature. 409:2001;733-739.
4. Tsuboi S., Fukuda M. Branched O-linked oligosaccharides ectopically expressed in transgenic mice reduce primary T-cell immune responses. EMBO J. 16:1997;6364-6373.
5. Moody A.M., Chui D., Reche P.A., Priatel J.J., Marth J.D., Reinherz E.L. Developmentally regulated glycosylation of the CD8alphabeta coreceptor stalk modulates ligand binding. Cell. 107:2001;501-512.
6. Daniels M.A., Devine L., Miller J.D., Moser J.M., Lukacher A.E., Altman J.D., Kavathas P., Hogquist K.A., Jameson S.C. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity. 15:2001;1051-1061.
7. Salomon B., Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19:2001;225-252.
8. Thompson C.B. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell. 81:1995;979-982.
9. Aruffo A., Seed B. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA. 84:1987;8573-8577.
10. Hanawa H., Ma Y., Mikolajczak S.A., Charles M.L., Yoshida T., Yoshida R., Strathdee C.A., Litchfield D.W., Ochi A. A novel costimulatory signaling in human T lymphocytes by a splice variant of CD28. Blood. 99:2002;2138-2145.
11. Cai Y.C., Cefai D., Schneider H., Raab M., Nabavi N., Rudd C.E. Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation. Immunity. 3:1995;417-426.
12. DeBenedette M.A., Chu N.R., Pollok K.E., Hurtado J., Wade W.F., Kwon B.S., Watts T.H. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J. Exp. Med. 81:1995;985-992.
13. Fargeas C.A., Truneh A., Reddy M., Hurle M., Sweet R., Sekaly R.P. Identification of residues in the V domain of CD80 (B7-1) implicated in Functional interactions with CD28 and CTLA-4. J. Exp. Med. 182:1995;667-675.
14. Maggirwar S.B., Harhaj E.W., Sun S.C. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors. Mol. Cell. Biol. 17:1997;2605-2614.
15. Rudd P.M., Wormald M.R., Stanfield R.L., Huang M., Mattsson N., Speir J.A., DiGennaro J.A., Fetrow J.S., Dwek R.A., Wilson I.A. Roles for glycosylation of cell surface receptors involved in cellular immune recognition. J. Mol. Biol. 293:1999;351-366.
16. Nehring R.B., Richter D., Meyerhof W. Glycosylation affects agonist binding and signal transduction of the rat somatostatin receptor subtype 3. J. Physiol. Paris. 94:2000;185-192.
17. Kamitani S., Sakata T. Glycosylation of human CRLR at Asn123 is required for ligand binding and signaling. Biochim. Biophys. Acta. 1539:2001;131-139.
18. Srikrishna G., Huttunen H.J., Johansson L., Weigle B., Yamaguchi Y., Rauvala H., Freeze H.H. N-Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth. J. Neurochem. 80:2002;998-1008.
19. van der Merwe P.A., Bodian D.L., Daenke S., Linsley P., Davis S.J. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185:1997;393-403.
20. Delves P.J. The role of glycosylation in autoimmune disease. Autoimmunity. 27:1998;239-253.